MicroRNA Market to Grow with a CAGR of 11.45% through 2030
Advancements in Genomic Research and Growing Emphasis on Biomarker Discovery are expected to drive the Global MicroRNA Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “MicroRNA Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global
MicroRNA Market stood at USD 1548.30 Million in 2024 and is anticipated to grow
with a CAGR of 11.45% in the forecast period, 2026-2030.
The growing prevalence of chronic diseases worldwide is a primary driver behind the expansion of the global MicroRNA (miRNA) market. MicroRNAs, small non-coding RNA molecules, have gained considerable attention for their potential as biomarkers in the diagnosis and management of a wide range of diseases, particularly cancer, cardiovascular disorders, and neurological conditions. miRNAs are able to reflect the molecular intricacies of these diseases, providing valuable insights into the underlying biological mechanisms. This capability has positioned miRNAs as indispensable tools in early diagnosis, disease prognosis, and the formulation of personalized treatment plans, especially in the era of precision medicine.
In recent years, the field of miRNA research has experienced a transformative shift due to significant advancements in sequencing and profiling technologies. The advent of high-throughput sequencing techniques has revolutionized the pace and accuracy of miRNA discovery. Researchers are now able to identify and profile miRNAs with unprecedented precision and at a much faster rate than before. This has enabled comprehensive studies into the expression patterns of miRNAs across a variety of diseases, shedding light on their roles as critical biomarkers. These advancements have also driven the development of more targeted diagnostic tools, facilitating early detection and enabling more precise therapeutic interventions.
As a result of these technological breakthroughs, miRNAs have become integral components of diagnostic strategies, especially in the context of personalized medicine. Personalized medicine focuses on tailoring healthcare treatments to individual patients based on their unique genetic, environmental, and lifestyle factors. miRNAs, with their ability to provide real-time insights into the molecular mechanisms of disease, have proven essential in identifying the most appropriate treatment strategies for patients. This has expanded the role of miRNAs from simply being biomarkers to becoming active participants in the treatment decision-making process.
The discovery of miRNAs as biomarkers in liquid biopsies has ushered in new possibilities for non-invasive diagnostic techniques. Liquid biopsies, which involve the analysis of biomarkers found in blood or other bodily fluids, have emerged as a less invasive alternative to traditional tissue biopsies. miRNAs can be detected in these samples, enabling the monitoring of disease progression and treatment response in real time, without the need for invasive procedures. This has not only improved the comfort and safety of patients but has also led to significant advancements in the early detection and monitoring of diseases such as cancer, cardiovascular disorders, and neurological conditions.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global MicroRNA Market”
The Global
MicroRNA Market is segmented into Products & Services, End-Use, Application, Regional Distribution, And Company.
Based
on the End-Use, Biotechnology & Pharmaceutical emerged as the
dominant segment in the global market for Global MicroRNA Market in 2024. Biotechnology and pharmaceutical companies have invested heavily in research and development related to microRNA. They have the resources and expertise to conduct extensive research, which includes identifying and characterizing microRNAs, as well as exploring their potential applications in diagnostics and therapeutics. These companies are well-equipped to translate research findings into practical products and services. They can develop innovative microRNA-based diagnostic tests, therapeutic agents, and other related solutions. Biotechnology and pharmaceutical companies have experience in conducting clinical trials, which are crucial for testing the safety and efficacy of microRNA-based therapeutics and diagnostics. They also possess regulatory expertise to navigate the complex approval processes. These companies have established distribution networks and sales channels that allow them to reach a global market. This access to healthcare providers, laboratories, and healthcare systems is essential for commercializing microRNA products. Many of these companies have secured intellectual property rights for microRNA-related discoveries, technologies, and applications. This intellectual property can provide a competitive advantage and protect their innovations.
The Asia Pacific is poised to witness fastest market growth in the MicroRNA Market during the forecast period. the primary catalysts for this rapid market growth is the region’s rising prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and neurological disorders. Asia Pacific countries, such as China and India, are witnessing significant increases in the incidence of these conditions, which are often linked to lifestyle changes, aging populations, and environmental factors. As a result, there is a growing demand for effective diagnostic and therapeutic solutions, which has increased the focus on miRNA as a key tool for early detection, personalized medicine, and disease monitoring.
The increasing adoption of advanced healthcare technologies is another key factor propelling the miRNA market in the APAC region. The growth of healthcare infrastructure and significant investments in biotechnology and genomics research in countries like China, India, and Japan are contributing to the development of cutting-edge diagnostic and therapeutic tools. High-throughput sequencing technologies, which are essential for miRNA profiling, have gained substantial traction in the region. The integration of these technologies in research and clinical applications enables more accurate and efficient miRNA detection, boosting the region's potential for breakthrough diagnostics and treatments in the near future.
Major companies
operating in MicroRNA Market are:
- Thermo Fisher
Scientific, Inc.
- Horizon
Discovery Ltd.
- OriGene
Technologies, Inc.
- QIAGEN
- GeneCopoeia,
Inc.
- Merck KGaA
- Miltenyi Biotec
- Sistemic
Scotland Limited
- SeqMatic LLC
- Biodynamics Laboratory Inc.
Download Free Sample Report
Customers can
also request for 10% free customization
on this report
“The global MicroRNA (miRNA) market is poised for significant growth, driven by advancements in diagnostic and therapeutic technologies, the increasing prevalence of chronic diseases, and the shift toward personalized medicine. miRNAs have proven to be invaluable tools in early disease detection, prognosis, and the development of targeted treatments, particularly in oncology, cardiovascular, and neurological conditions. As research progresses and technology continues to evolve, miRNA-based solutions are expected to play an increasingly pivotal role in reshaping healthcare, with regions such as Asia Pacific emerging as key growth hubs. With continued investment in biotechnology, strong government support, and rising demand for innovative, non-invasive diagnostic options, the miRNA market is well-positioned for sustained expansion, offering vast opportunities for stakeholders across the global healthcare and biotechnology sectors”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.
“MicroRNA market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Products, Consumables, Services), By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other end users), By Region, and Competition, 2020-2030F”,
has evaluated the future growth potential of Global MicroRNA Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global MicroRNA Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com